4-Andro

4-Andro Overview

4-Androstenediol (4-Andro) is an androstenediol-type steroid precursor that is structurally related to dehydroepiandrosterone (DHEA). In research models, compounds from the androstenediol family are studied for how structural differences may influence androgen-related signaling pathways and receptor interactions.

In laboratory settings, 4-Androstenediol is investigated for its role in steroidogenic conversion pathways, particularly its potential enzymatic transformation into downstream steroid hormones such as testosterone. Research also explores how androgen-related steroid compounds may interact with biochemical pathways involved in hormone signaling and metabolism.

Chemical and Molecular Properties

Property	Information
CAS Number	1156-92-9
Molecular Formula	C19H30O2
Molecular Mass	290.4 g/mol
Synonyms	4-Androstenediol, Androst-4-ene-3beta,17beta-diol, G10EHA9I0D, 4-ANDENDIOL
IUPAC Name	(3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
Storage	15-30°C (59-86°F)

Mechanism of Action

Current research investigates the potential enzymatic conversion of 4-Androstenediol (4-Andro) into downstream steroid hormones under controlled experimental conditions.

Studies have evaluated:

• Conversion into testosterone through steroidogenic enzymes such as 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase
• Aromatization pathways in which testosterone-derived metabolites may form estradiol through aromatase activity
• Comparative pathway utilization when evaluated alongside related steroid precursors such as androstenedione

One controlled investigation reported temporary elevations in serum testosterone during short-term administration of androstenedione-related precursor compounds. These levels were observed to return to normal during extended observation periods. Additional studies have also examined the formation of aromatization-related metabolites during similar experimental research protocols.

Potential Research Applications

Published literature has examined DHEA and androstenediol-related compounds across multiple controlled experimental settings.

IGF-1 Signaling Pathways

Certain controlled studies have reported measurable variations in circulating insulin-like growth factor-1 (IGF-1) concentrations during monitored research protocols involving DHEA-related compounds.

Steroidogenic Conversion Dynamics

Investigations have assessed the enzymatic conversion potential of androstenediol-related compounds into downstream steroid hormones under laboratory conditions.

Muscle Physiology Markers

Some research protocols have evaluated musculoskeletal performance metrics alongside endocrine markers in defined study populations.

Neuroendocrine & Cortisol-Related Parameters

Exploratory research has examined associations between DHEA-related compounds and neuroendocrine markers.

Note: 4-Andro is not approved by the FDA for medical uses. It is available for investigational and research purposes only.

Where to Buy 4-Androstenediol?

PureRawz offers high-quality 4-Andro for laboratory and research applications. The compound is prepared under controlled production conditions to help ensure consistency for experimental studies.

All our products undergo strict quality control procedures. An independent third-party Certificate of Analysis (COA) is provided to confirm the compound’s identity, purity, and overall quality for reliable research use.

Disclaimer

This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use

References:

PubChem. (2026). 4-Androstenediol. Nih.gov; PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/4-Androstenediol

Wolkowitz, O. M., Reus, V. I., Roberts, E., Manfredi, F., Chan, T., Raum, W. J., Ormiston, S., Johnson, R., Canick, J., Brizendine, L., & Weingartner, H. (1997). Dehydroepiandrosterone (DHEA) treatment of depression. Biological Psychiatry, 41(3), 311’318. https://doi.org/10.1016/s0006-3223(96)00043-1

Villareal, D. T., & Holloszy, J. O. (2004). Effect of DHEA on abdominal fat and insulin action in elderly women and men. JAMA, 292(18), 2243. https://doi.org/10.1001/jama.292.18.2243

Sripada, R. K., Marx, C. E., King, A. P., Rajaram, N., Garfinkel, S. N., Abelson, J. L., & Liberzon, I. (2013). DHEA enhances emotion regulation, neurocircuits, and modulates memory for emotional stimuli. Neuropsychopharmacology, 38(9), 1798’1807. https://doi.org/10.1038/npp.2013.79